Premkumar Christadoss M.B.B.S., formed Immune Globe Biotech, LLC in 2014. He is the President, CEO, CSO and Senior Scientist at IGBT. He graduated from Madras Medical College in 1977 and did his postdoctoral training in Immunology at the Mayo Clinic and was awarded the MDA postdoctoral fellowship. He was recruited to UTMB from the University of Vermont in 1990 and promoted to Professor with tenure in 1997.
He has an independent research program related to the cellular and molecular mechanisms of autoimmune myasthenia gravis pathogenesis and the development of specific therapy for this disease. He has published 110 articles, mostly in MG and mostly in peer reviewed high impact journals. He is the primary inventor on three issued patents related to diagnosis and biomarkers and therapy of MG with complement siRNA. He is also the editor of an authoritative published book on MG: Mechanisms of Disease and Immunointervention. He was Honorary Professor at Central South China University and has achieved national and international recognition, as evidenced in part by invitations to speak at Oxford, Karolinsaka and the Weizmann Institute.
Dr. Christadoss has funded his research program at the University of Texas Medical Branch, Galveston, Texas, with awards from the Muscular Dystrophy Association, NIH, pharmaceutical companies, the Association Francaise Centre les Myopathies, MGFA and MGFI. Additionally, he has been successful at obtaining national and international support for his predoctoral and postdoctoral fellows. Dr. Christadoss has received a Fulbright fellowship at Hellenic Pasteur Institute, Greece in 2000. His research program is highly recognized internationally.